Yi Hu

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 15

Top Topics

Stem Cell Transplantation

Endoscopic Submucosal Dissection

Helicobacter Pylori

Top Venues

The American journal of gastroenterology

Journal of translational medicine

Disease markers

This page only lists publications with an associated author ORCID identifier.

Publications

Ren-Chun Du, Xing Liu, Yong-Kang Lai, Yu-Xin Hu, Hao Deng, Hui-Qiao Zhou, Nong-Hua Lu, Yin Zhu, Yi Hu
Exploring the performance of ChatGPT on acute pancreatitis-related questions. Journal of translational medicine 22 (1) (2024)
Ren-Chun Du, Xing Liu, Yong-Kang Lai, Yu-Xin Hu, Hao Deng, Hui-Qiao Zhou, Nong-Hua Lu, Yin Zhu, Yi Hu
Exploring the performance of ChatGPT on acute pancreatitis-related questions. Journal of translational medicine 22 (1) (2024)
Ren-Chun Du, Nong-Hua Lu, Yi Hu
Is 10-Day Vonoprazan With High-Dose Amoxicillin Dual Therapy Efficient for Eradicating Helicobacter pylori Infection in China? The American journal of gastroenterology (2024)
Ren-Chun Du, Xing Liu, Yong-Kang Lai, Yu-Xin Hu, Hao Deng, Hui-Qiao Zhou, Nong-Hua Lu, Yin Zhu, Yi Hu
Exploring the performance of ChatGPT on acute pancreatitis-related questions. Journal of translational medicine 22 (1) (2024)
Ren-Chun Du, Nong-Hua Lu, Yi Hu
Is 10-Day Vonoprazan With High-Dose Amoxicillin Dual Therapy Efficient for Eradicating Helicobacter pylori Infection in China? The American journal of gastroenterology 119 (4) (2023)
Ren-Chun Du, Nong-Hua Lu, Yi Hu
Is 10-Day Vonoprazan With High-Dose Amoxicillin Dual Therapy Efficient for Eradicating Helicobacter pylori Infection in China? The American journal of gastroenterology 119 (4) (2023)
Ren-Chun Du, Nong-Hua Lu, Yi Hu
Is 10-Day Vonoprazan With High-Dose Amoxicillin Dual Therapy Efficient for Eradicating Helicobacter pylori Infection in China? The American journal of gastroenterology 119 (4) (2023)
Yong Xie, Yi Hu, Yin Zhu, Hong Wang, Qi-Zhi Wang, Yan-Qing Li, Jiang-Bin Wang, Zhen-Yu Zhang, De-Kui Zhang, Xiao-Wei Liu, Nong Hua Lu
Colloidal bismuth pectin-containing quadruple therapy as the first-line treatment of Helicobacter pylori infection: A multicenter, randomized, double-blind, non-inferiority clinical trial. Helicobacter (2023)
Yi Hu, Xin Xu, Yao-Bin Ouyang, Cong He, Nian-Shuang Li, Chuan Xie, Chao Peng, Zhen-Hua Zhu, Yong Xie, Xu Shu, Nong Hua Lu, Yin Zhu
Analysis of oral microbiota alterations induced by Helicobacter pylori infection and vonoprazan-amoxicillin dual therapy for Helicobacter pylori eradication. Helicobacter 27 (5) (2022)
Yi Hu, Nong Hua Lu
Letter: a promising Helicobacter pylori regimen - vonoprazan-based therapy. Alimentary pharmacology & therapeutics 56 (4) (2022)
Yi Hu, Xin Xu, Yao-Bin Ouyang, Cong He, Nian-Shuang Li, Chuan Xie, Chao Peng, Zhen-Hua Zhu, Yong Xie, Xu Shu, Nong Hua Lu, Yin Zhu
Optimization of vonoprazan-amoxicillin dual therapy for eradicating Helicobacter pyloriinfection in China: A prospective, randomized clinical pilot study. Helicobacter 27 (4) (2022)
Yaobin Ouyang, Minghui Wang, Yu-Ling Xu, Yin Zhu, Nong Hua Lu, Yi Hu
Amoxicillin-vonoprazan dual therapy for Helicobacter pylori eradication: A systematic review and meta-analysis. Journal of gastroenterology and hepatology 37 (9) (2022)
Huan Wang, Nian-Shuang Li, Cong He, Chuan Xie, Yin Zhu, Nong Hua Lu, Yi Hu
Discovery and Validation of Novel Methylation Markers in Helicobacter pylori -Associated Gastric Cancer. Disease markers 2021 (2021)
Hong-Yan Chen, Yi Hu, Xin-Bo Xu, Yan-An Zhou, Nian-Shuang Li, Cong He, Chuan Xie, Nong Hua Lu, Yin Zhu
Upregulation of oncogene Activin A receptor type I by Helicobacter pylori infection promotes gastric intestinal metaplasia via regulating CDX2. Helicobacter 26 (6) (2021)
Yi Hu, Yaobin Ouyang, Yin Zhu, Nong Hua Lu
Reverse hybrid therapy for Helicobacter pylori eradication: A systematic review and meta-analysis. Helicobacter 26 (2) (2021)